Natural Capsules Stock Screener | Share Price & Fundamental Analysis
NATCAPSUQ
Pharmaceuticals
Share Price NSE
₹151.15
▲
2.33 (1.57%)
Share Price BSE
₹150.00
▲
0.65 (0.44%)
Track Natural Capsules share price live with TickJournal's free stock screener.
Analyze Natural Capsules share price history trends and compare 52-week high low
levels.
Calculate NATCAPSUQ stock fair value using fundamental analysis and view live share price charts.
Determine Natural Capsules share intrinsic value and compare it with current NATCAPSUQ share price.
Record your Natural Capsules trades in TickJournal's free trading journal and track your portfolio performance.
Natural Capsules Market Cap
₹156.20 Cr.
EPS (TTM)
₹0.23
Dividend Yield
-
Debt to Equity
0.49
NATCAPSUQ 52 Week High
₹278.00
Natural Capsules 52 Week Low
₹148.82
Operating Margin
-6.00%
Profit Margin
-18.42%
NATCAPSUQ Revenue (TTM)
₹38.00
EBITDA
₹-2.00
Net Income
₹-7.00
Total Assets
₹419.00
Total Equity
₹257.00
Natural Capsules Share Price History - Stock Screener Chart
Screen NATCAPSUQ historical share price movements with interactive charts. Analyze price trends and patterns.
Natural Capsules Company Profile - Fundamental Screener
Screen Natural Capsules company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NATCAPSUQ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE936B01015
Natural Capsules Balance Sheet Screener
Screen NATCAPSUQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total Assets | 419 | 377 | 289 | 164 | 97 | 75 | 73 | 71 |
| Current Assets | 130 | 124 | 102 | 76 | 50 | 38 | 38 | 42 |
| Fixed Assets | 284 | 103 | 97 | 67 | 38 | 24 | 24 | 22 |
| Liabilities | ||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 62 | 71 | 74 | 37 | 2 | 1 | 1 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||
| Total Equity | 257 | 229 | 148 | 83 | 62 | 56 | 56 | 54 |
| Share Capital | 10 | 9 | 9 | 7 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 223 | 195 | 114 | 76 | 56 | 49 | 49 | 48 |
Natural Capsules Income Statement Screener - Profit & Revenue Analysis
Screen Natural Capsules income statement and profit fundamentals.
Analyze NATCAPSUQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Natural Capsules share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38 | 46 | 46 | 45 | 44 | 41 | 39 | 41 | 41 | 38 | 38 | 38 | 46 | 45 | 44 |
| Expenses | 40 | 47 | 45 | 41 | 40 | 37 | 35 | 36 | 35 | 32 | 32 | 32 | 36 | 35 | 35 |
| EBITDA | -2 | -1 | 1 | 5 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 10 | 10 | 9 |
| Operating Profit % | -6.00% | -2.00% | 1.00% | 10.00% | 10.00% | 11.00% | 11.00% | 10.00% | 12.00% | 14.00% | 16.00% | 15.00% | 21.00% | 21.00% | 21.00% |
| Depreciation | 4 | 4 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -9 | -8 | -6 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 7 | 7 | 7 |
| Tax | -2 | -1 | -1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Net Profit | -7 | -7 | -6 | 1 | 0 | -1 | 1 | 1 | 1 | 2 | 2 | 2 | 5 | 5 | 5 |
| EPS | -6.88 | -6.76 | -5.40 | 0.13 | 0.10 | -0.60 | 0.65 | 1.31 | 1.29 | 1.67 | 1.96 | 1.85 | 5.68 | 6.85 | 7.43 |
Natural Capsules Cash Flow Screener - Liquidity Fundamentals
Screen NATCAPSUQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | 27 | -8 | 17 | -1 | 6 | 7 | 2 | 5 |
| Investing Activities | -45 | -73 | -105 | -46 | -9 | -6 | -7 | -1 |
| Financing Activities | 16 | 82 | 88 | 48 | 3 | -1 | 4 | -4 |
| Net Cash Flow | -2 | 1 | 0 | 1 | 0 | 0 | -1 | 1 |
Natural Capsules Shareholding Pattern Screener
See Natural Capsules shareholding pattern with promoter, FII, and DII holdings.
Check Natural Capsules promoter holding and ownership changes for NATCAPSUQ on TickJournal.
| Item | 2025-Feb | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.14% | 51.21% | 51.26% | 51.26% | 51.26% | 56.56% | 56.56% | 51.60% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.31% | 0.18% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 32.86% | 33.09% | 33.04% | 32.94% | 32.95% | 34.72% | 35.10% | 32.26% |
| Other Holding | 16.01% | 15.70% | 15.69% | 15.80% | 15.79% | 7.41% | 8.16% | 16.14% |
| Shareholder Count | 9,552 | 9,425 | 9,311 | 9,573 | 9,075 | 10,954 | 10,514 | 9,995 |
Natural Capsules Share Dividend Screener - Share Yield Analysis
Check Natural Capsules dividend history with payout and yield data.
View Natural Capsules dividend details including ex-dates and amounts for NATCAPSUQ stock.
Natural Capsules Stock Index Membership
See which indices include Natural Capsules stock.
Check NATCAPSUQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Natural Capsules Market Events Screener - Corporate Actions
Get Natural Capsules corporate actions including splits, bonuses, and buybacks.
Check Natural Capsules stock events that may affect NATCAPSUQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.00 /share | 29.27% | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 0.63% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.85% |
| 2025-08-04 | 2025-08-04 | Annual General Meeting | NA | -3.27% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -0.46% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 2.49% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -10.56% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -4.42% |
| 2024-08-23 | 2024-08-23 | Extraordinary General Meeting | NA | -5.93% |
| 2024-07-26 | 2024-07-26 | Annual General Meeting | NA | 9.84% |
| 2023-07-20 | 2023-07-20 | Dividend | ₹ 1.00 /share | -19.69% |
| 2021-11-11 | 2021-11-12 | Rights | 1:2 | 33.36% |
| 2021-07-06 | 2021-07-08 | Dividend | ₹ 1.00 /share | 1.21% |
Natural Capsules Competitors Screener - Peer Comparison
Screen NATCAPSUQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 434,951 | 39.60 | 54,729 | 9.71% | 10,980 | 68.53 |
| Divis Laboratories | 169,157 | 67.86 | 9,712 | 18.67% | 2,191 | 54.94 |
| Torrent Pharmaceuticals | 149,857 | 65.11 | 11,539 | 6.99% | 1,911 | 67.69 |
| Dr Reddys Laboratories | 109,721 | 19.44 | 33,741 | 16.73% | 5,725 | 59.67 |
| Cipla | 107,716 | 23.61 | 28,410 | 7.12% | 5,291 | 45.99 |
| Lupin | 106,772 | 22.53 | 22,910 | 13.74% | 3,306 | 65.36 |
| Zydus Life Science | 92,885 | 18.19 | 23,511 | 18.55% | 4,615 | 55.14 |
| Mankind Pharma | 92,373 | 49.50 | 12,744 | 20.90% | 2,007 | 59.18 |
| Aurobindo Pharma | 74,685 | 20.78 | 32,346 | 9.43% | 3,484 | 67.28 |
| Alkem Laboratories | 67,154 | 26.95 | 13,458 | 3.70% | 2,216 | 51.57 |
Natural Capsules Company Announcements - News Screener
Screen NATCAPSUQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-24 | Letter To Shareholders | View |
| 2026-02-24 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2026-02-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-13 | Announcement Under Regulation 30 | View |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-02-13 | Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended December 31 2025. | View |
| 2026-02-13 | Board Meeting Outcome for Held On Friday February 13 2026. | View |
| 2026-02-04 | Board Meeting Intimation for Considering And Approving The Unaudited Consolidated & Standalone Financial Results Of The Company For The Quarter Ended 31St December 2025. | View |
| 2026-01-30 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-03 | Announcement Under Regulation 30(9) Of SEBI (LODR) Regulations 2015 | View |
| 2025-12-26 | Announcement Under Regulation 30 Of SEBI( LODR) Regulations 2015 | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-12-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |